# NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

> **NCT04999046** · NA · COMPLETED · sponsor: **NaviFUS Corporation** · enrollment: 12 (actual)

## Conditions studied

- Drug Resistant Epilepsy
- Seizure
- Seizure Disorder
- Epilepsy

## Interventions

- **DEVICE:** NaviFUS System

## Key facts

- **NCT ID:** NCT04999046
- **Lead sponsor:** NaviFUS Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-07
- **Primary completion:** 2024-05-13
- **Final completion:** 2024-07-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04999046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04999046, "NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04999046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*